Phase II Phosphatidylinositol 3-Kinase (PI3K) Inhibitor in Relapsed, Indolent or Aggressive Non-Hodgkin’s Lymphomas (NHL)
by on Wednesday, August 8th, 2012 | No Comments
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: BAY80-6946
Sponsors: Bayer; Bayer
Not yet recruiting – verified August 2012